Closing soonSpecial Notice4 days left

Specific Anti-Alpha-Gal ImmunoCAPTM Phadia Core Laboratory Testing (ThermoFisher Scientific) for Research Blood Donors

Health and Human Services, Department of · NATIONAL INSTITUTES OF HEALTH

Opportunity details

Specific Anti-Alpha-Gal ImmunoCAPTM Phadia Core Laboratory Testing (ThermoFisher Scientific) for Research Blood Donors is currently listed as accepting responses on SAM.gov. Buyer context: Health and Human Services, Department of · NATIONAL INSTITUTES OF HEALTH. Industry classification: In-Vitro Diagnostic Substance Manufacturing (NAICS 325413). Product/service classification: REFERENCE LABORATORY TESTING (PSC Q301). Set-aside: No Set aside used. Performance location: Bethesda, MD, USA. Notice type: Special Notice. GovGazette adds public award history and related pages to help you decide whether to keep reading. Check all requirements on SAM.gov.

  • Check the NAICS and PSC codes, set-aside rules, place of performance, and time left before the deadline.
  • This notice lists a set-aside (No Set aside used). Confirm your certification and size status under the official SBA and agency rules before you spend time on a proposal.
  • This page uses 44 related public awards. The range describes past awards; it does not set a bid price.
  • Use the NAICS and PSC pages to find other open notices under the same codes.
Response deadline
Aug 2, 2026, 12:00 PM EDT
Set-aside
No Set aside used
Place of performance
Bethesda, MD, USA
Posted
Jul 23, 2026
Solicitation
NOI-CC-OLAO-26-008249
Contracting office
NATIONAL INSTITUTES OF HEALTH · Bethesda · MD
Source
SAM.gov

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Phadia Acquisition Description: ThermoFisher Scientific Phadia Immunology Reference Laboratory (PiRL), optimizes laboratory workflows for allergy and autoimmune diagnostics including alpha-gal and total immunoglobulin E (IgE), providing calibrated, reliable testing data with efficiency and improved turnaround time for clinical and research use. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-008249) by 12:00 PM eastern standard time on 08/2/2026 to: [email protected]. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

What similar awards have paid

See what agencies paid for similar work. This public history does not set a bid price, estimate a cost, or predict an award.

Typical award size

$106,458

Middle of the pack for similar past awards

Most similar awards fall between $68,275 and $212,445

Lower end$68,275Typical$106,458Higher end$212,445
Based on 44 similar awardsIn-Vitro Diagnostic Substance Manufacturing325413REFERENCE LABORATORY TESTINGQ301Prime contracts, excluding umbrella award vehicles

Who has won work like this

These firms won similar public awards. Use the list for competitor research or teaming, not as a ranking.

Drawn from official USAspending contract records. Always confirm requirements on the SAM.gov notice before you bid.

For research only. This is not legal advice or a promise of an award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Open the original SAM.gov notice for the official record.

Federal vendorsMore from Health and Human Services, Department ofIn-Vitro Diagnostic Substance Manufacturing325413REFERENCE LABORATORY TESTINGQ301Maryland contracts